Figure 4.
Phases of opportunistic infections in CD19-targeted CAR–T-cell therapy recipients.aApproximately 50% of bacteremia episodes are due to gram-positive organisms and 50% are due to gram-negative organisms. The conceptual model for this figure was adapted from Tomblyn et al.35